UW Spinout OnLume Awarded $2M Grant

OnLume has been awarded a $2 million grant from the U.S. National Institutes of Health’s National Cancer Institute to advance the development of its proprietary device for Fluorescence-Guided Surgery (FGS), the company announced today. “We …

FluGen CEO talks Covid-19 vaccine development

At Wisconsin Inno’s latest virtual event, Paul Radspinner, the president and CEO of FluGen, revealed the startup’s progress on developing a Covid-19 vaccine as the pandemic rages on its seventh month. The event, which took …